Neovacs SA
Share Statistics
As of December 31, 2024, Neovacs SA has 269,590.00 shares outstanding.
| Shares Outstanding | 269,590.00 |
Financial Position
As of December 31, 2024, Neovacs SA maintains a current ratio of 0.63, meaning it holds 0.6x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.63 |
| Quick Ratio | 0.11 |
| Debt / Equity | 1.28 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2024.
| Employee Count | 19.00 |
Stock Price Statistics
EURAs of the close on October 23, 2026, Neovacs SA's stock has declined approximately 99.99% over the past 52 weeks. The 50-day moving average sits at 0.30, while the 200-day moving average is 107.59.
| 52-Week Price Change | -99.99% |
| 50-Day Moving Average | 0.30 |
| 200-Day Moving Average | 107.59 |
Balance Sheet
EURAs of December 31, 2024, Neovacs SA holds 435,449.00 in cash and equivalents against 230,367.00 in total debt, resulting in a net debt position of -205,074.00. Total book value stands at 18.06M, with working capital of -1.50M providing operational flexibility.
| Cash & Cash Equivalents | 435,449.00 |
| Total Debt | 230,367.00 |
| Net Debt | -205,074.00 |
| Equity (Book Value) | 18.06M |
| Book Value Per Share | 67.00 |
| Working Capital | -1.50M |
Stock Splits
Neovacs SA's most recent stock split took place on June 23, 2026 with a 10000:1 split ratio.
| Last Split Date | 6/23/2026 |
| Split Ratio | 10000:1 |